Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001601485-25-000062
Filing Date
2025-04-09
Accepted
2025-04-09 16:18:40
Documents
14
Period of Report
2025-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A angn-20250409.htm   iXBRL DEF 14A 505285
3 angn-20250409_g1.jpg GRAPHIC 28117
4 angn-20250409_g2.jpg GRAPHIC 349252
5 angn-20250409_g3.jpg GRAPHIC 399631
  Complete submission text file 0001601485-25-000062.txt   2610167

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20250409.xsd EX-101.SCH 792
16 EXTRACTED XBRL INSTANCE DOCUMENT angn-20250409_htm.xml XML 958
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39990 | Film No.: 25825435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)